2009 Executive Officer Compensation Arrangements for Jazz Pharmaceuticals, Inc.

Summary

This document outlines the 2009 base salary rates for executive officers of Jazz Pharmaceuticals, Inc., including the Chairman and CEO, President, and other senior executives. It also notes that Dr. Samuel R. Saks resigned as CEO effective April 3, 2009, and entered into a consulting agreement for one year, though he has not performed any consulting services to date. The agreement specifies the compensation amounts for each executive and clarifies the employment status of Dr. Saks.

EX-10.84 2 dex1084.htm 2009 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS 2009 Executive Officer Compensation Arrangements

Exhibit 10.84

2009 Executive Officer Compensation Arrangements


Executive Officer		2009 Base Salary Rate ($)
Bruce C. Cozadd Chairman and Chief Executive Officer		421,200
Samuel R. Saks, M.D.⁽¹⁾ Former Chief Executive Officer		421,200
Robert M. Myers President		399,600
Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary		339,150
Janne L. T. Wissel Senior Vice President and Chief Regulatory Officer		321,300
Joan E. Colligan Principal Accounting Officer and Acting Principal Financial Officer		210,000

⁽¹⁾

Dr. Saks resigned his position with the company effective April 3, 2009 and has not received any compensation since that date. Dr. Saks executed a consulting agreement with us effective April 4, 2009 through April 3, 2010, but to date has not performed any consulting for us pursuant to that agreement.